The efficacy and safety of darbepoetin alfa for treating anemia in low-risk myelodysplastic syndrome patients: Results after 53/55 weeks.

被引：0
|
作者：
Gabrilove, Janice
Paquette, Ronald
Lyons, Roger M.
Mushtaq, Chaudhry
Sekeres, Mikkael A.
Lam, Hung
Dreiling, Lyndah
机构：
[1] Mt Sinai Sch Med, Dept Med, New York, NY USA
[2] Univ Calif Los Angeles, Ctr Oncol, Los Angeles, CA USA
[3] Canc Care Ctr S Texas, US Oncol Res, San Antonio, TX USA
[4] S Carolina Oncol Associates, Columbia, SC USA
[5] Taussig Canc Ctr, Cleveland Clin, Cleveland, OH 44106 USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2671.2671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2671
引用
收藏
页码：755A / 755A
页数：1
相关论文
共 50 条
  • [21] Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: Two case reports
    Duarte F.B.
    Lemes R.P.G.
    Dos Santos T.E.D.J.
    Barbosa M.C.
    De Vasconcelos J.P.L.
    Rocha-Filho F.D.
    Zalcberg I.
    Coutinho D.
    Figueiredo M.F.
    Carlos L.B.
    De Vasconcelos P.R.L.
    Journal of Medical Case Reports, 11 (1) : 1 - 4
  • [22] Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b
    Shimoda, Kazuya
    Qin, Albert
    Komatsu, Norio
    Kirito, Keita
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (02) : 151 - 156
  • [23] Efficacy and Safety of Romiplostim in Patients with Low or Intermediate-Risk Myelodysplastic Syndrome (MDS) Receiving Decitabine
    Greenberg, Peter L.
    Garcia-Manero, Guillermo
    Moore, Michael R.
    Damon, Lloyd E.
    Roboz, Gail J.
    Wei, Helen
    Kantarjian, Hagop
    Franklin, Janet L.
    BLOOD, 2009, 114 (22) : 703 - 703
  • [24] Antithymocyte globulin (ATG) has limited efficacy in anemic patients with low-risk myelodysplastic syndrome (MDS): Results of a prematurely terminated phase IItrial.
    Steensma, DP
    Dispenzieri, A
    Schroeder, G
    Tefferi, A
    BLOOD, 2002, 100 (11) : 338B - 338B
  • [25] Treating anemia of cancer with every-4-week darbepoetin alfa: Final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study
    Gordon, David
    Nichols, Gwen
    Ben-Jacob, Ali
    Tomita, Dianne
    Lillie, Tom
    Miller, Carole
    ONCOLOGIST, 2008, 13 (06): : 715 - 724
  • [26] Successful treatment of low-risk myelodysplastic syndrome-related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
    Kunimoto, Hiroyoshi
    Sakuma, Takayuki
    Ohashi, Takuma
    Shirafuta, Mayoko
    Teranaka, Hiroshi
    Nakajima, Hideaki
    EJHAEM, 2024,
  • [27] The avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients: Efficacy and safety results after 97 weeks
    Kishnani, Priya
    Diaz-Manera, Jordi
    Kushlaf, Hani
    Ladha, Shafeeq
    Mozaffar, Tahseen
    Straub, Volker
    Toscano, Antonio
    van der Ploeg, Ans T.
    Berger, Kenneth I.
    Clemens, Paula R.
    Chien, Yin-Hsiu
    Day, John W.
    Illarioshkin, Sergey
    Roberts, Mark
    Attarian, Shahram
    Carvalho, Gerson
    Choi, Young-Chul
    Erdem-Ozdamar, Sevim
    Goker-Alpan, Ozlem
    Kostera-Pruszczyk, Anna
    Haack, Kristina An
    Thibault, Nathan
    Zhou, Tianyue
    Dimachkie, Mazen M.
    Schoser, Benedikt
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S66 - S67
  • [28] Presence of CD34+ in Megakaryocytes in Association With p53 Expression Predicts Unfavorable Prognosis in Low-risk Myelodysplastic Syndrome Patients
    De Jesus Dos Santos, Talyta Ellen
    Duarte, Fernando Barroso
    Barbosa, Maritza Cavalcante
    Gadelha Moura, Anna Thawanny
    Leitao De Vasconcelos, Joao Paulo
    Rocha-Filho, Francisco Dario
    Coutinho, Diego F.
    Zalcberg, Ilana
    Vasconcelos, Paulo R. L.
    Oliverira Garcia, Yhasmine Delles
    Goncalves Lemes, Romelia Pinheiro
    IN VIVO, 2019, 33 (01): : 277 - 280
  • [29] Efficacy and Safety of Long-Term Ropeginterferon Alfa-2b Treatment in Patients with Low-Risk and High-Risk Polycythemia Vera (PV)
    Kiladjian, Jean-Jacques
    Klade, Christoph
    Georgiev, Pencho
    Krochmalczyk, Dorota
    Gercheva-Kyuchukova, Liana
    Egyed, Miklos
    Dulicek, Petr
    Illes, Arpad
    Pylypenko, Halyna
    Sivcheva, Lylia
    Mayer, Jiri
    Yablokova, Vera
    Krejcy, Kurt
    Empson, Victoria
    Hasselbalch, Hans Carl
    Kralovics, Robert
    Gisslinger, Heinz
    BLOOD, 2022, 140 : 9663 - 9664
  • [30] Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study
    Mittelman, Moshe
    Henry, David H.
    Glaspy, John
    Tombak, Anil
    Harrup, Rosemary Anne
    Madry, Krzysztof
    Grabowska, Barbara
    Platzbecker, Uwe
    Lee, Tyson
    Modelska, Katharina
    BLOOD, 2023, 142
12345